Yüklüyor......

405例肺癌合并肺结核患者临床特征及驱动基因检测分析

BACKGROUND AND OBJECTIVE: New treatment methods such as targeted therapy and immune checkpoint inhibitors have been applied to lung cancer patients. It is necessary to further understand the patients with lung cancer combined with pulmonary tuberculosis with the development of lung cancer research....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Zhongguo Fei Ai Za Zhi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 中国肺癌杂志编辑部 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7260389/
https://ncbi.nlm.nih.gov/pubmed/32336065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.25
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!